Unraveling the Serotonergic Mechanism of Stress-Related Anxiety: Focus on Co-Treatment with Resveratrol and Selective Serotonin Reuptake Inhibitors
<b>Background/Objectives:</b> In post-traumatic stress disorder (PTSD), anxiety-like symptoms are often associated with elevated noradrenaline levels and decreased serotonin. Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat anxiety, but elevated serotonin has...
Saved in:
Main Authors: | Vadim E. Tseilikman, Olga B. Tseilikman, Marina N. Karpenko, Dmitrii S. Traktirov, Daria A. Obukhova, Vladislav A. Shatilov, Maxim S. Zhukov, Gennady V. Manuilov, Oleg N. Yegorov, Maxim R. Aristov, Ilya A. Lipatov, Irina A. Buksha, Alexandr E. Epitashvili, Anton A. Pashkov, Jurica Novak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-10-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/12/11/2455 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Are Selective Serotonin Reuptake Inhibitors a Secondary Cause of Low Bone Density?
by: Kim Chau, et al.
Published: (2012-01-01) -
Selective Serotonin Reuptake Inhibitors in Human Pregnancy: To Treat or Not to Treat?
by: Orna Diav-Citrin, et al.
Published: (2012-01-01) -
Ankle edema after administration of selective serotonin reuptake inhibitors
by: Konstantinos Kontoangelos, et al.
Published: (2018-06-01) -
Selective Serotonin Reuptake Inhibitors and Associated Bleeding Risks: A Narrative and Clinical Review
by: Amber N. Edinoff, et al.
Published: (2022-11-01) -
Comparative study between high and low dose methylene blue infusion in septic cancer patients: a randomized, blinded, controlled study
by: Ehab Hanafy Shaker, et al.
Published: (2025-01-01)